Investing.com - Bath & Body Works (NYSE: BBWI) reported third quarter EPS of $0.48, $0.13 better than the analyst estimate of $0.35. Revenue for the quarter came in at $1.56B versus the consensus estimate of $1.56B.
Guidance
Bath & Body Works sees Q4 2024 EPS of $1.70-$1.90 versus the analyst consensus of $1.98.
Bath & Body Works sees FY 2024 EPS of $2.90-$3.10 versus the analyst consensus of $3.07.
Bath & Body Works's stock price closed at $32.50. It is down -11.01% in the last 3 months and down -16.60% in the last 12 months.
Bath & Body Works saw 5 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Bath & Body Works's stock price’s past reactions to earnings here.
According to InvestingPro, Bath & Body Works's Financial Health score is "good performance".
Check out Bath & Body Works's recent earnings performance, and Bath & Body Works's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar